Press release
Peptide Based Hematological Disorders Therapeutics Market Set to Deliver Major Revenue Shares during the Forecast Period
Get free Sample Report @ https://www.factmr.com/connectus/sample?flag=S&rep_id=189
On the other hand, the synthesis and the purification of long peptides is difficult for manufacturers. In addition, the rise in modifications and the addition of more number of unnatural amino acids have made the process of peptide synthesis complex. This makes the manufacturing of peptides difficult, and hence the gap between demand and supply is increasing and the cost of manufacturing of peptides is also accelerating, thereby hampering market growth.
The global peptide based hematological disorders therapeutics market is slated to touch a value of nearly US$ 530 Mn in the year 2022 and grow at a robust CAGR during the assessment period.
North America Market Set to Dominate the Global Peptide Based Hematological Disorders Therapeutics Market in Terms of Revenue
The market in North America is set to dominate the global peptide based hematological disorders therapeutics market in terms of value and this trend is projected to sustain itself throughout the assessment period. North America peptide based hematological disorders therapeutics market is the most attractive market, growing at a robust CAGR over the assessment period.
View Full Report with Table of Content: https://www.factmr.com/report/189/peptide-based-hematological-disorders-therapeutics-market
Icatibant Segment Poised to Touch a Value of Nearly US$ 410 Mn in 2022
As per the forecast of Fact.MR, the icatibant segment is expected to reach a value of nearly US$ 410 Mn in the year 2022. This represents a robust CAGR during the forecast period of 2017-2022. Icatibant segment is expected to account for more than three-fourth of the revenue share of the drug segment by the year 2017 and is expected to lose market share by the end of the year 2022.
Hospital Pharmacies Segment to exhibit a CAGR of 7.4% During the Assessment Period
As per the forecast of Fact.MR, the hospital pharmacies segment is slated to touch a figure of nearly US$ 260 Mn in the year 2022. This represents a CAGR of 7.4% during the assessment period from 2017 till the year 2022. This segment is expected to lose market share by the end of the year 2022. The hospital pharmacies segment is expected to account for more than half of the revenue share of the distribution channel segment by the year 2017.
Competition Tracking
The report also profiles companies that are expected to remain active in the expansion of global peptide based hematological disorders therapeutics market through 2022, which includes Shire plc.
Have Any Query? Discuss with Our Expert Team @ https://www.factmr.com/connectus/sample?flag=AE&rep_id=189
Contact Us
Fact.MR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/
Blog: https://factmrblog.com/
Read Industry News at - https://www.industrynewsanalysis.com/
About Fact.MR
Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Peptide Based Hematological Disorders Therapeutics Market Set to Deliver Major Revenue Shares during the Forecast Period here
News-ID: 1769648 • Views: …
More Releases from Fact.MR
United States Motor Protection Devices Industry Insights 2025-2035: Regional Bre …
The United States motor protection devices industry is projected to expand from approximately USD 2.1 billion in 2025 to around USD 3.0 billion by 2035, reflecting a compound annual growth rate (CAGR) of 3.7%. This growth is being driven by increasing industrial automation, the deployment of smart protection systems, and rising electricity safety standards across key U.S. sectors.
Motor protection devices-including motor circuit breakers, thermal overload relays, and electronic motor protectors-play…
European Medical Plastic Compounds Market Forecast 2025-2035: Innovation, Growth …
The global medical plastic compounds market is projected to grow from approximately USD 83.4 billion in 2025 to around USD 141.3 billion by 2035, representing a compound annual growth rate (CAGR) of 5.4%. This rapid expansion is being fueled by escalating demand for medical devices, increasing adoption of single-use healthcare products, and growing integration of advanced polymer technologies in clinical and manufacturing applications.
Medical plastic compounds-tailored formulations of polymers used to…
United States Marine Sensors Industry Analysis 2025-2035: Key Developments and F …
The United States marine sensors industry is projected to grow from approximately USD 9.8 billion in 2025 to around USD 16.3 billion by 2035, at a compound annual growth rate (CAGR) of 5.2%. This strong growth is driven by rising demand for maritime automation, increased offshore energy exploration, and growing investment in naval and commercial vessel sensor systems.
Marine sensors-instruments that measure parameters like flow, pressure, level, environmental chemistry, and acoustic…
Probiotic Dairy Products - Top Global Industry Trends in 2026
The global probiotic dairy products market is set for robust expansion from 2025 to 2035, supported by rising consumer focus on gut health, surging demand for functional foods, and the acceleration of preventive healthcare trends. Probiotic dairy products-including yogurt, fermented milk, kefir, cheese, and drinkable probiotic formulations-play a central role in supporting digestive health, immunity, and overall wellness.
This press release outlines the market size, growth catalysts, regional perspectives, technology trends,…
More Releases for Peptide
Copper Peptide GHK-Cu Market: Empowering Beauty and Health Innovations with Adva …
The global copper peptide GHK-Cu market is poised for transformative growth as innovative cosmetic and pharmaceutical formulations increasingly incorporate these bioactive peptides to promote skin rejuvenation, wound healing, and overall wellness. Driven by technological advancements, growing consumer awareness of anti-aging solutions, and an expanding portfolio of product applications, the market is set to evolve rapidly in the coming years. This industry provides an in-depth analysis of market information, key growth…
Shaping the Cell Penetrating Peptide Market in 2025: Innovative Peptide Drug Dis …
How Big Is the Cell Penetrating Peptide Market Expected to Be, and What Will Its Growth Rate Be?
In recent times, the market size for cell penetrating peptides has expanded swiftly. The market is projected to rise from a value of $1.87 billion in 2024 to $2.16 billion in 2025, growing at a compound annual growth rate (CAGR) of 15.6%. The historic period's growth can be credited to an amplified comprehension…
Cancer Peptide Drugs Market
Global Peptide Cancer Drug Market Size, Dosage, Drug Price, Sales & Clinical Trials Insight 2030 Report Highlights:
• Global Peptide Cancer Drug Market Insight By Region & Indication
• Global Peptide Cancer Drug Market Opportunity: > US$ 18 Billion
• Approved Peptide Cancer Drugs: > 30 Drugs
• Approved Peptide Cancer Drugs Sales Insights, Patent, Dosage and Price Analysis
• Peptide Cancer Drugs Clinical Trials Insight By Company, Country, Indication and Phase
• Insight On Peptide Cancer Drugs In Clinical Trials: >…
Growing Adoption of Synthetic Peptide Drugs Driving Peptide Therapeutics Market …
Peptide Therapeutics Market size was valued at USD 40.69 billion in 2019 and is poised to grow from USD 43.11 billion in 2023 to USD 68.4 billion by 2031, growing at a CAGR of 5.94% in the forecast period (2024-2031).
[https://www.skyquestt.com/report/peptide-therapeutics-market] size was valued at USD 43.11 billion in 2023 to USD 68.4 billion by 2031, growing at a CAGR of 5.94% in the forecast period (2024-2031). The increasing prevalence of…
Global Adjuvant Peptide Market Size,Share, Research and Forecast,2023-2028| Pept …
The global Adjuvant Peptide market is carefully researched in the report while largely concentrating on top players and their business tactics, geographical expansion, market segments, competitive landscape, manufacturing, and pricing and cost structures. Each section of the research study is specially prepared to explore key aspects of the global Adjuvant Peptide market. For instance, the market dynamics section digs deep into the drivers, restraints, trends, and opportunities of the global…
Peptide Modifications For PEGylation
PEGylation is the process of covalently attaching polyethylene glycol (PEG) polymer chains to peptides. By increasing their molecular mass and shielding them from proteolytic enzymes, PEGylation improves the pharmacokinetics of peptides and proteins. PEGylation reduces renal clearance and results in more sustained absorption after subcutaneous administration, as well as restricted distribution. PEGylations have been shown to significantly improve water solubility, biocompatibility, immunogenicity, and other physico-chemical properties. It is an established…
